Catalys Pacific, Llc Portfolio Stock Holdings

According to the SEC 13F filed on October 30, 2026, Catalys Pacific, Llc disclosed 2 stock positions valued at approximately $209.74M as of quarter-end September 30, 2026. The largest holdings include Mineralys Therapeutics, Inc. and Phathom Pharmaceuticals, Inc..

Report Period
September 30, 2026
No. of Stocks
2
Portfolio Value
$209.74M
Holdings by Sector
Catalys Pacific, Llc Portfolio Holdings in Q3 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
Mineralys Therapeutics, Inc.MLYSHealthcare93.45%7,799,518-104,320-1.32%$196,001,887
Phathom Pharmaceuticals, Inc.PHATHealthcare6.55%1,882,039+388,185+25.99%$13,738,885
Showing 2 of 2 holdings in the latest reporting period.